Endophytic and rhizosphere fungi are understood to be aiding the host plant to overcome a range of biotic and abiotic stresses (nutrition depletion, droughts, etc.) hence, they remain to be reservoirs of plethora of natural products with immense use. Consequently, this investigation of endophytic and rhizosphere fungi isolated from Mikania cordata (a perennial vine that is well established in Sri Lanka) for their antimicrobial properties was performed with the aim of future derivation of potential beneficial pharmaceutical products. Leaves, twigs, and roots of M. cordata were utilized to isolate a total of 9 endophytic fungi out of which the highest amount (44%) accounted was from the twigs. A sample of the immediate layer of soil adhering to the root of M. cordata was utilized to isolate 15 rhizosphere fungi. Fusarium equiseti and Phoma medicaginis were endophytes that were identified based on colony and molecular characteristics. The broad spectrum of antimicrobial activity depicted by F. equiseti (MK517551) was found to be significantly greater (p ≤ 0.05, inhibitory against Bacillus cereus ATCC 11778, Staphylococcus aureus ATCC 25923, Escherichia coli ATCC 25922, and Pseudomonas aeruginosa ATCC 25853) than P. medicaginis (MK517550) (inhibitory against Staphylococcus aureus ATCC 25923, Escherichia coli ATCC 25922, and Pseudomonas aeruginosa ATCC 25853) as assessed using the Kirby‐Bauer disk diffusion method. Trichoderma virens and Trichoderma asperellum were rhizospere fungi that exhibited remarkable antimicrobial properties against the test pathogens chosen for the study. T. asperellum indicated significantly greater bioactivity against all four bacterial pathogens and Candida albicans ATCC 10231 under study. The ranges of minimum inhibitory concentrations (MICs) of the fungi depicting antimicrobial properties were determined. The results obtained suggest that F. equiseti, P. medicaginis, T. asperellum, and T. virens of M. cordata harness bioprospective values as natural drug candidates. This is the first report on isolation and evaluation of the antimicrobial properties of endophytic and rhizosphere fungi of Mikania cordata.
10 November 2020 in Biochemistry Research International
Infectious diseases and diabetes mellitus are counted responsible for a substantial amount of mortality among the human population. The current study was performed to detect the antimicrobial activities and hypoglycemic potential of Mikania cordata (Asteraceae) leaves extracted into aqueous media and several organic solvents (ethyl acetate and methanol). The ethyl acetate extract of Mikania cordata (MEA) leaves was observed to possess significantly ( ) greater antimicrobial capabilities (susceptible against Bacillus cereus ATCC 11778 and Staphylococcus aureus ATCC 25923) when compared with that of the methanol (MME) and aqueous extracts (MDW) which were assessed based on Kirby-Bauer disk diffusion assay. The minimum inhibitory concentration of MEA (against B. cereus, S. aureus, and Escherichia coli ATCC 25922) and MME (against B. cereus, S. aureus, E. coli, and Candida albicans ATCC 10231) lies in a similar range of 1.13 > MIC>0.56 mg/ml. In the present study, a single compound (from MEA) of Rf value 0.64 was isolated by thin-layer chromatography (TLC) that was responsible for the zone of inhibition against B. cereus (20.3 ± 0.3 mm). The results of this study also depicted the antihyperglycemic properties of M. cordata leaves which followed the same trend as the commercial drug Metformin in a glucose concentration-independent manner when tested in a glucose uptake assay by yeast cells. Therefore, it is evident that Mikania cordata is a reservoir of useful bioactive compounds which with further research will be paving the path for drug commercialization. This is the first record of TLC-based isolation of antimicrobial compounds of M. cordata and analysis of the hypoglycemic properties of M. cordata leaves.
The alarming rise in diabetic cases and the severity of their complications, including nephropathy, neuropathy, and cardiovascular disease (CVD), among the world’s population has drawn much attention in the past years. Specifically, the number of cases have drawn the interest of researchers to pay more attention in developing novel therapeutics to battle and manage diabetes in a more efficient manner. This would in turn help minimize the global financial burden on patient care and rehabilitation costs of diabetes and its complications. The use of botanical, naturally derived organic therapeutics have drawn much interest as the demand grows for novel therapeutic agents to combat diabetes. Novel herbal therapeutic agents could be considered as a valuable and an effective bridge between modern science and traditional folk medicine. The controversy about the mode of action, efficacy, and overall result of the natural products derived from medicinal herbs exists mostly due to the clinical data in the form of anecdotal reports and poorly controlled studies. However, from the patient’s perspective, natural botanical extracts have gained confidence from public due to them being a part of the culture for several generations. One such plant is the Mikania cordata vine, which is one of the most commonly utilized herbal application as a wound healing agent. It harbors a myriad of other bioactive compounds that await exploration, including antimicrobials and particularly antidiabetic compounds. The antidiabetic effects of M. cordata leaves as assessed by the assay of glucose uptake by yeast indicates strong antidiabetic activity in a dose-dependent manner comparable to metformin, which is a proven medicine used in diabetes. Furthermore, its antidiabetic activity was proportionate to the external glucose concentration which is a huge therapeutic advantage as a potential antidiabetic agent. This chapter outlines the therapeutic uses of M. cordata with special attention to its ability to lower blood glucose levels. <!----> <!----> <!----> <!---->